Medicine and Dentistry
Endothelin 1
100%
Angiotensin II
63%
Endothelial Cell
27%
Promoter Region
27%
Cardiovascular System
18%
Vascular Endothelium
18%
Epigenetic Mechanism
18%
Ventricular Hypertrophy
18%
Synapsin I
18%
Histone
18%
Cardiomyopathy
18%
Therapeutic Procedure
18%
In Vitro
9%
Depletion
9%
Oncogene C Fos
9%
Combination Therapy
9%
Pathological Process
9%
Screening
9%
Cardiomyocyte
9%
Histone Modification
9%
Transcription Initiation
9%
Cardiac Fibrosis
9%
Histone Methyltransferase
9%
Host
9%
Pathology
9%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelin 1
100%
Angiotensin II
63%
Synapsin I
18%
Hypertrophy
18%
Histone
18%
Mouse
18%
Heart Ventricle Hypertrophy
18%
Cardiomyopathy
18%
Vasoconstrictor Agent
9%
Heart Muscle Fibrosis
9%
Host
9%
Histone Methyltransferase
9%
Chemistry
Endothelin-1
100%
Angiotensin II
63%
Histone
36%
Protein
18%
Aqueous Solution
9%
Procedure
9%
Molecule
9%
Concentration
9%
Chemical Activation
9%
Synthesis (Chemical)
9%
Cardiovascular
9%
Modification
9%
Biochemistry, Genetics and Molecular Biology
Endothelin 1
100%
Promoter Region
27%
Transcription
27%
Histone
18%
Mouse
18%
Screening
9%
Transcription Initiation
9%
C-Fos
9%
Small Molecule
9%
Host
9%
Histone Modification
9%
Histone Methyltransferase
9%
Synthesis
9%
Solution and Solubility
9%
Agricultural and Biological Sciences
Angiotensin II
63%
Endothelial Cells
27%
Histones
18%
Cytochromes
18%
Mice
18%
Transactivation
9%
Cardiac Muscle Cell
9%
Screening
9%
Objectives
9%
Hosts
9%
Solutions
9%